Cargando…

Interleukin-15 and irisin serum concentrations are not related to cardiometabolic risk factors in patients with type 2 diabetes from Korea and Germany

Detalles Bibliográficos
Autores principales: Choi, Kyung Mook, Hwang, Soon Young, Han, Kyungdo, Chung, Hye Soo, Kim, Nam Hoon, Yoo, Hye Jin, Seo, Ji-A., Kim, Sin Gon, Kim, Nan Hee, Baik, Sei Hyun, Ebert, Thomas, Fasshauer, Mathias, Blüher, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049542/
https://www.ncbi.nlm.nih.gov/pubmed/31506722
http://dx.doi.org/10.1007/s00592-019-01417-3
_version_ 1783502461502226432
author Choi, Kyung Mook
Hwang, Soon Young
Han, Kyungdo
Chung, Hye Soo
Kim, Nam Hoon
Yoo, Hye Jin
Seo, Ji-A.
Kim, Sin Gon
Kim, Nan Hee
Baik, Sei Hyun
Ebert, Thomas
Fasshauer, Mathias
Blüher, Matthias
author_facet Choi, Kyung Mook
Hwang, Soon Young
Han, Kyungdo
Chung, Hye Soo
Kim, Nam Hoon
Yoo, Hye Jin
Seo, Ji-A.
Kim, Sin Gon
Kim, Nan Hee
Baik, Sei Hyun
Ebert, Thomas
Fasshauer, Mathias
Blüher, Matthias
author_sort Choi, Kyung Mook
collection PubMed
description
format Online
Article
Text
id pubmed-7049542
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer Milan
record_format MEDLINE/PubMed
spelling pubmed-70495422020-03-16 Interleukin-15 and irisin serum concentrations are not related to cardiometabolic risk factors in patients with type 2 diabetes from Korea and Germany Choi, Kyung Mook Hwang, Soon Young Han, Kyungdo Chung, Hye Soo Kim, Nam Hoon Yoo, Hye Jin Seo, Ji-A. Kim, Sin Gon Kim, Nan Hee Baik, Sei Hyun Ebert, Thomas Fasshauer, Mathias Blüher, Matthias Acta Diabetol Short Communication Springer Milan 2019-09-10 2020 /pmc/articles/PMC7049542/ /pubmed/31506722 http://dx.doi.org/10.1007/s00592-019-01417-3 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Short Communication
Choi, Kyung Mook
Hwang, Soon Young
Han, Kyungdo
Chung, Hye Soo
Kim, Nam Hoon
Yoo, Hye Jin
Seo, Ji-A.
Kim, Sin Gon
Kim, Nan Hee
Baik, Sei Hyun
Ebert, Thomas
Fasshauer, Mathias
Blüher, Matthias
Interleukin-15 and irisin serum concentrations are not related to cardiometabolic risk factors in patients with type 2 diabetes from Korea and Germany
title Interleukin-15 and irisin serum concentrations are not related to cardiometabolic risk factors in patients with type 2 diabetes from Korea and Germany
title_full Interleukin-15 and irisin serum concentrations are not related to cardiometabolic risk factors in patients with type 2 diabetes from Korea and Germany
title_fullStr Interleukin-15 and irisin serum concentrations are not related to cardiometabolic risk factors in patients with type 2 diabetes from Korea and Germany
title_full_unstemmed Interleukin-15 and irisin serum concentrations are not related to cardiometabolic risk factors in patients with type 2 diabetes from Korea and Germany
title_short Interleukin-15 and irisin serum concentrations are not related to cardiometabolic risk factors in patients with type 2 diabetes from Korea and Germany
title_sort interleukin-15 and irisin serum concentrations are not related to cardiometabolic risk factors in patients with type 2 diabetes from korea and germany
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049542/
https://www.ncbi.nlm.nih.gov/pubmed/31506722
http://dx.doi.org/10.1007/s00592-019-01417-3
work_keys_str_mv AT choikyungmook interleukin15andirisinserumconcentrationsarenotrelatedtocardiometabolicriskfactorsinpatientswithtype2diabetesfromkoreaandgermany
AT hwangsoonyoung interleukin15andirisinserumconcentrationsarenotrelatedtocardiometabolicriskfactorsinpatientswithtype2diabetesfromkoreaandgermany
AT hankyungdo interleukin15andirisinserumconcentrationsarenotrelatedtocardiometabolicriskfactorsinpatientswithtype2diabetesfromkoreaandgermany
AT chunghyesoo interleukin15andirisinserumconcentrationsarenotrelatedtocardiometabolicriskfactorsinpatientswithtype2diabetesfromkoreaandgermany
AT kimnamhoon interleukin15andirisinserumconcentrationsarenotrelatedtocardiometabolicriskfactorsinpatientswithtype2diabetesfromkoreaandgermany
AT yoohyejin interleukin15andirisinserumconcentrationsarenotrelatedtocardiometabolicriskfactorsinpatientswithtype2diabetesfromkoreaandgermany
AT seojia interleukin15andirisinserumconcentrationsarenotrelatedtocardiometabolicriskfactorsinpatientswithtype2diabetesfromkoreaandgermany
AT kimsingon interleukin15andirisinserumconcentrationsarenotrelatedtocardiometabolicriskfactorsinpatientswithtype2diabetesfromkoreaandgermany
AT kimnanhee interleukin15andirisinserumconcentrationsarenotrelatedtocardiometabolicriskfactorsinpatientswithtype2diabetesfromkoreaandgermany
AT baikseihyun interleukin15andirisinserumconcentrationsarenotrelatedtocardiometabolicriskfactorsinpatientswithtype2diabetesfromkoreaandgermany
AT ebertthomas interleukin15andirisinserumconcentrationsarenotrelatedtocardiometabolicriskfactorsinpatientswithtype2diabetesfromkoreaandgermany
AT fasshauermathias interleukin15andirisinserumconcentrationsarenotrelatedtocardiometabolicriskfactorsinpatientswithtype2diabetesfromkoreaandgermany
AT bluhermatthias interleukin15andirisinserumconcentrationsarenotrelatedtocardiometabolicriskfactorsinpatientswithtype2diabetesfromkoreaandgermany